TickerFactsScreenerDevelopers

CytomX Therapeutics, Inc. (CTMX) — Net Income

Annual figures by fiscal year, from SEC filings.

2013: -$15.14M2014: -$30.31M2015: -$35.37M2016: -$58.90M2017: -$43.10M2018: -$84.60M2019: -$132.82M2020: -$64.82M2021: -$115.87M2022: -$99.32M2023: -$569.0K2024: $31.87M2025: -$17.37M-$17.37M
2013Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$17.37M-154.5%
2024$31.87M+5700.9%
2023-$569.0K+99.4%
2022-$99.32M+14.3%
2021-$115.87M-78.8%
2020-$64.82M+51.2%
2019-$132.82M-57.0%
2018-$84.60M-96.3%
2017-$43.10M+26.8%
2016-$58.90M-66.5%
2015-$35.37M-16.7%
2014-$30.31M-100.2%
2013-$15.14M—